Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detection

Open access

Abstract

Artificial intelligence models using digital histopathology slides stained with hematoxylin and eosin offer promising, tissue-preserving diagnostic tools for patients with cancer. Despite their advantages, their clinical utility in real-world settings remains unproven. Assessing EGFR mutations in lung adenocarcinoma demands rapid, accurate and cost-effective tests that preserve tissue for genomic sequencing. PCR-based assays provide rapid results but with reduced accuracy compared with next-generation sequencing and require additional tissue. Computational biomarkers leveraging modern foundation models can address these limitations. Here we assembled a large international clinical dataset of digital lung adenocarcinoma slides ( N = 8,461) to develop a computational EGFR biomarker. Our model fine-tunes an open-source foundation model, improving task-specific performance with out-of-center generalization and clinical-grade accuracy on primary and metastatic specimens (mean area under the curve: internal 0.847, external 0.870). To evaluate real-world clinical translation, we conducted a prospective silent trial of the biomarker on primary samples, achieving an area under the curve of 0.890. The artificial-intelligence-assisted workflow reduced the number of rapid molecular tests needed by up to 43% while maintaining the current clinical standard performance. Our retrospective and prospective analyses demonstrate the real-world clinical utility of a computational pathology biomarker.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-025-03780-x

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 80

Metadata

Authors
Campanella, G., Kumar, N., Nanda, S., Singi, S., Fluder, E., Kwan, R., Muehlstedt, S., Pfarr, N., Schüffler, P. J., Häggström, I., Neittaanmäki, N., Akyürek, L. M., Basnet, A., Jamaspishvili, T., Nasr, M. R., Croken, M. M., Hirsch, F. R., Elkrief, A., Yu, H., Ardon, O., Goldgof, G. M., Hameed, M., Houldsworth, J., Arcila, M., Fuchs, T. J., & Vanderbilt, C.
Affiliations
  • Icahn School of Medicine at Mount Sinai (US)
  • Memorial Sloan Kettering Cancer Center (US)
  • Technical University of Munich (DE)
  • Chalmers University of Technology (SE)
  • Sahlgrenska University Hospital (SE)
  • SUNY Upstate Medical University (US)
  • Tisch Cancer Institute (US)
  • Université de Montréal (CA)
Corresponding author
  • Fuchs, Thomas J.
  • Vanderbilt, Chad
Venue
Nature Medicine
Published
2025-07-09
Volume
31
Issue
9
Pages
3002-3010
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W4412151081
Cited by
69
References
19
Citations by year
2026: 59 · 2025: 10
FWCI
27.58
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • Chalmers Research (Chalmers University of Technology) (submittedVersion)
Funders
  • Warren Alpert Foundation
  • U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA008748)
Topics
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
Keywords
EGFR mutation testing, lung adenocarcinoma, digital histopathology, computational pathology, pathology foundation models, fine-tuning, metastatic lung cancer, clinical translation, rapid molecular diagnostics, H&E staining
MeSH terms
Adenocarcinoma of Lung, Artificial Intelligence, Female, Humans, Lung Neoplasms, Male, Mutation, Biomarkers, Tumor, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detection. https://app.cochat.ai/papers/10.1038/s41591-025-03780-x
The paper
Campanella, G., Kumar, N., Nanda, S., Singi, S., Fluder, E., Kwan, R., Muehlstedt, S., Pfarr, N., Schüffler, P. J., Häggström, I., Neittaanmäki, N., Akyürek, L. M., Basnet, A., Jamaspishvili, T., Nasr, M. R., Croken, M. M., Hirsch, F. R., Elkrief, A., Yu, H., . . . Vanderbilt, C. (2025). Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detection. Nature Medicine. https://doi.org/10.1038/s41591-025-03780-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.